DEPOSIT AGREEMENT by and among TIGENIX as Issuer, DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER Dated as of [●], 20[●]Deposit Agreement • December 22nd, 2015 • Deutsche Bank Trust Co Americas/ ADR Group • Pharmaceutical preparations • New York
DEPOSIT AGREEMENT, dated as of [●], 20[●], by and among (i) TiGenix, a limited liability company (naamloze vennootschap/société anonyme) incorporated under the laws of Belgium, having its registered office at Romeinse Straat 12 box 2, 3001 Leuven, Belgium enterprise number 0471.340.123 RPR Leuven (together with its successors, the “Company”), (ii) Deutsche Bank Trust Company Americas, an indirect wholly owned subsidiary of Deutsche Bank A.G., acting in its capacity as depositary, with its principal office at 60 Wall Street, New York, NY 10005, United States of America and any successor depositary hereunder (the “Depositary”) and (iii) all Holders and Beneficial Owners of American Depositary Shares evidenced by American Depositary Receipts issued hereunder (all such capitalized terms as hereinafter defined).
